EP11.03. Profile of Patients with NSCLC Who Benefit from Immunochemotherapy. Real-World Data from the Multicenter Polish Lung Cancer Group Study - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Magdalena Knetki-Wróblewska
Meta Tag
Speaker Magdalena Knetki-Wróblewska
Topic Metastatic NSCLC: Immunotherapy - Retrospective
stage IV non-small cell lung cancer
platin-based chemotherapy
patient subpopulations
progression-free survival
overall survival
objective response rate
favorable prognosis
metastatic NSCLC
Powered By